Navigation Links
Researchers put the bite on mosquitoes
Date:1/16/2008

Few things sting like a mosquito's bite--especially if that bite carries a disease such as malaria, yellow fever, Dengue fever or West Nile virus. But if researchers from The University of Arizona in Tucson have their way, one day mosquito bites may prove deadly to the mosquitoes as well.

"Our goal is to turn the female mosquito's blood meal into the last meal she ever eats," said project leader Roger L. Miesfeld, a professor of biochemistry and molecular biophysics in UA's College of Science and a member of BIO5 and the Arizona Cancer Center.

Other UA researchers involved with the project include Patricia Y. Scaraffia, Guanhong Tan, Jun Isoe, BIO5 member Vicki H. Wysocki, and the late Michael A. Wells.

These researchers have discovered that one particular mosquito species, Aedes aegypti, has a surprisingly complex metabolic pathway, one that requires its members to excrete toxic nitrogen after gorging on human blood. If the mosquitoes fail to do so, they'll also fail to lay eggs--and will likely sicken and die.

Scaraffia, a research assistant professor in UA's department of biochemistry and molecular biophysics, and the other members of the team published their findings in the January 15 issue of the Proceedings of the National Academy of Sciences. The research was funded by the National Institutes of Health.

Miesfeld and his colleagues are seeking a molecule that is harmless to humans, but will gum up the works of mosquito metabolism, forcing the mosquitoes to hang onto the nitrogen. Such a molecule would kill both the mosquitoes and their would-be progeny--thus slowing the spread of disease.

Once found, this molecule--and similar molecules aimed at other mosquito species--could be developed into an insecticide and sprayed in places where mosquitoes congregate, such as around water and on mosquito netting.

The researchers also envision developing an oral insecticide--a mosquito-slaying pill that members of a community with a high instance of, say, yellow fever or malaria might take to reduce the mosquito population. The pill wouldn't be a vaccine; if people who took it were later bitten by a disease-carrying mosquito, they would still become infected. However, the mosquito would ingest the insecticide along with the blood, causing her to bear fewer young and possibly die before she could bite anyone else.

"The whole community would essentially become one big mosquito trap," Miesfeld said. Over time, mosquito populations and disease rates would both decline. "It would be a group effort that in the long run could have a huge impact."

In a world where both mosquitoes and the diseases they carry are becoming increasingly resistant to known insecticides and medicines, finding new ways to fight them is crucial.

"This would be one more weapon in our arsenal against diseases that kill millions of people a year," Miesfeld said.


'/>"/>

Contact: Deborah Daun
ddaun@email.arizona.edu
520-626-2059
University of Arizona
Source:Eurekalert  

Related biology news :

1. Researchers find association between food insecurity and developmental risk in children
2. Iowa State researchers look for smaller, cheaper, 1-dose vaccines
3. Japanese and German researchers meet to discuss climate change
4. Type 1 diabetes triggered by lazy regulatory T-cells: McGill researchers
5. Researchers uncover new piece to the puzzle of human height
6. Researchers create mathematical model of fruit fly eyes
7. Snoozing worms help Penn researchers explain the evolution of sleep
8. Researchers move 2 steps closer to understanding genetic underpinnings of autism
9. Rices West honored as one of Texas best researchers
10. Stanford researchers publish review of US medical device regulation
11. University of Alberta researchers report breakthrough in lowering bad cholesterol, fatty acid levels
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Researchers put the bite on mosquitoes
(Date:4/13/2017)... MONICA, Calif. , April 13, 2017 ... New York will feature emerging and evolving ... Summits. Both Innovation Summits will run alongside the expo ... of speaker sessions, panels and demonstrations focused on trending ... coast,s largest advanced design and manufacturing event will take ...
(Date:4/11/2017)... Research and Markets has announced the addition ... their offering. ... tracking market to grow at a CAGR of 30.37% during the ... 2017-2021, has been prepared based on an in-depth market analysis with ... its growth prospects over the coming years. The report also includes ...
(Date:4/6/2017)... April 6, 2017 Forecasts by ... Document Readers, by End-Use (Transportation & Logistics, Government & ... Gas & Fossil Generation Facility, Nuclear Power), Industrial, Retail, ... Are you looking for a definitive report ... ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... (PRWEB) , ... October 12, ... ... today announces publication of a United States multicenter, prospective clinical study that ... disposable, point-of-care diagnostic test capable of identifying clinically significant acute bacterial and ...
(Date:10/11/2017)... ... October 11, 2017 , ... The ... endogenous context, enabling overexpression experiments and avoiding the use of exogenous expression plasmids. ... is transformative for performing systematic gain-of-function studies. , This complement to loss-of-function ...
(Date:10/11/2017)... LAGUNA HILLS, Calif. , Oct. 11, 2017 ... London (ICR) and University of ... prognostic tool to risk-stratify patients with multiple myeloma (MM), in ... nine . The University of Leeds ... by Myeloma UK, and ICR will perform the testing services ...
(Date:10/10/2017)... Los Angeles, CA (PRWEB) , ... ... ... Pharmaceuticals, Inc., a development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) ... all uses of targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed ...
Breaking Biology Technology: